Abacavir And Lamivudine Tablet, Film Coated
Product Images NDC 69097-362

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Abacavir And Lamivudine (NDC 69097-362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D306e740 28b8 4975 Acd3 5261dc07ed47 01

Chemical structure of Abacavir indicated within brackets, showing its molecular arrangement including a cyclopropyl group, a purine base with amino substitutions, and a cyclopentanol side chain, combined with two sulfate molecules (-H2SO4).*

FDA Label Image

D306e740 28b8 4975 Acd3 5261dc07ed47 02

Chemical structure diagram of the active ingredient Abacavir and Lamivudine, showing the molecular arrangement of atoms and bonds in the compound.*

FDA Label Image

D306e740 28b8 4975 Acd3 5261dc07ed47 03

Label for Abacavir and Lamivudine Tablets, USP, 600 mg/300 mg film-coated tablets. The label indicates 30 tablets per package, manufactured by Cipla Ltd. and Cipla USA Inc. It includes dosage and storage instructions, warnings for authorized dispensers, and barcode with NDC 69097-362-02.*

FDA Label Image

D306e740 28b8 4975 Acd3 5261dc07ed47 04

Label for Abacavir and Lamivudine Tablets USP 600 mg/300 mg film coated tablets. The label specifies a 30-tablet package from Cipla USA Inc., noting prescription-only status. It includes dosage strength, manufacturer information, storage conditions, and a warning to authorized dispensers about providing a Medication Guide and Warning Card with each dispensed tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.